Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program

被引：8
|
作者：
Feit, Noah Z. [1 ]
Goldman, Debra A. [2 ]
Smith, Evan [3 ]
Deighan, Jenny [4 ]
Iasonos, Alexia [1 ,2 ]
Zivanovic, Oliver [3 ]
Hyman, David M. [1 ,5 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA
[4] Mem Sloan Kettering Ctr, Human Res Protect Program, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Early Drug Dev Serv, 1275 York Ave, New York, NY 10128 USA
来源：
JAMA ONCOLOGY | 2019年 / 5卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1001/jamaoncol.2018.7002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：570 / 572
页数：3
相关论文
共 50 条
  • [21] US Food and Drug Administration defends use of placebo-controlled trials
    Larkin, M
    [J]. LANCET, 2000, 356 (9235): : 1086 - 1086
  • [22] SAFETY PATIENT IN MEDICATION USE AND ADMINISTRATION
    Casado Verdejo, Ines
    Postigo Mota, Salvador
    Iglesias Guerra, Jose Antonio
    Galan Andres, Ma Isabel
    Duran Gomez, Noelia
    Munoz Bermejo, Laura
    [J]. REVISTA ROL DE ENFERMERIA, 2011, 34 (03): : 208 - 211
  • [23] Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Greene, Stephen J.
    Aggarwal, Rahul
    Bhatt, Ankeet S.
    McMurray, John J. V.
    Fonarow, Gregg C.
    Solomon, Scott D.
    [J]. JAMA CARDIOLOGY, 2021, 6 (12) : 1415 - 1423
  • [24] Evidence Supporting US Food and Drug Administration Drug Safety Communications
    Ross, Joseph S.
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (11) : 1592 - 1592
  • [25] RAC APPROVES POLICY FOR SINGLE-PATIENT USE OF GENE-THERAPY
    JENKS, S
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04) : 266 - 267
  • [26] An Evaluation of US Food and Drug Administration's Program to Register HIV Drugs for Use in Resource-Constrained Settings
    Chahal, Harinder Singh
    Koukounas, Kalli
    Capella, Peter
    Presto, Ryan
    Murray, Jeffrey S.
    Shimer, Martin
    Riley, Karen
    Valdez, Mary Lou
    [J]. JAMA NETWORK OPEN, 2019, 2 (11)
  • [27] Food and Drug Administration Safety Communication on rhBMP-2 use Response
    Jea, Andrew
    Sayama, Christina
    Luerssen, Thomas G.
    [J]. JOURNAL OF NEUROSURGERY-PEDIATRICS, 2015, 16 (01) : 2 - 3
  • [28] Implications of Changes in US Food and Drug Administration Prescribing Information Regarding the Safety and Use of Asthma Biologics during Pregnancy
    Schatz, Michael
    Krishnan, Jerry A.
    Chambers, Christina
    [J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (10) : 1131 - 1136
  • [29] Impact of the US Food and Drug Administration's Safety-Related Announcements on the use of Bisphosphonates After Hip Fracture
    Kim, Seoyoung C.
    Kim, Dae Hyun
    Mogun, Helen
    Eddings, Wesley
    Polinski, Jennifer M.
    Franklin, Jessica M.
    Solomon, Daniel H.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (08) : 1536 - 1540
  • [30] Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis In A Us Expanded Access Program
    Lancaster, L.
    Morrison, L.
    Auais, A.
    Ding, B.
    Iqbal, A.
    Flaherty, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345